XT
DWTX

XTX Topco’s Dogwood Therapeutics DWTX Stock Holding History

XTX Topco’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,706
Closed -$9.17K – 2710
2024
Q2 		$9.17K Buy
+1,706
New +$14.8K ﹤0.01% 1697
2024
Q1 		– Sell
-910
Closed -$13.1K – 2416
2023
Q4 		$13.1K Buy
910
+332
+57% +$5.59K ﹤0.01% 1403
2023
Q3 		$13.4K Sell
578
-79
-12% -$2.75K ﹤0.01% 1410
2023
Q2 		$22.7K Buy
+657
New +$18.7K ﹤0.01% 1312

Other funds holding DWTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco's DWTX Position: Q3 2024 in Review

XTX Topco sold out of Dogwood Therapeutics (DWTX) in Q3 2024, closing a stake of 1,706 shares — an estimated $9.17K sold.

XTX Topco first reported a position in DWTX in Q2 2023 and held it in 4 quarters. The position peaked at $22.7K in Q2 2023. 24 funds tracked by Wall St. Rank hold DWTX as of Q3 2024.

  • XTX Topco reported no remaining Dogwood Therapeutics position as of Q3 2024 after selling out during the quarter.
  • XTX Topco sold 1,706 Dogwood Therapeutics shares in Q3 2024, an estimated $9.17K.
  • XTX Topco first reported a position in Dogwood Therapeutics in Q2 2023 and held it in 4 quarters.
  • XTX Topco's Dogwood Therapeutics position peaked at $22.7K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.